Masimo (MASI) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Masimo (MASI) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 64.73% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 29.56% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.89% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 60.12% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -66.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -66.51% |
| Jan 3, 2026 | -46.11% |
| Sep 27, 2025 | -82.38% |
| Jun 28, 2025 | -29.29% |
| Mar 29, 2025 | -88.29% |
| Dec 28, 2024 | -88.95% |
| Sep 28, 2024 | -31.05% |
| Jun 29, 2024 | -29.57% |
| Mar 30, 2024 | -30.98% |
| Dec 30, 2023 | -2.54% |
| Sep 30, 2023 | -40.13% |
| Jul 1, 2023 | -34.46% |
| Apr 1, 2023 | -30.86% |
| Dec 31, 2022 | -8.23% |
| Oct 1, 2022 | -8.26% |
| Jul 2, 2022 | -26.12% |
| Apr 2, 2022 | -1.87% |
| Jan 1, 2022 | 8.51% |
| Oct 2, 2021 | 0.39% |
| Jul 3, 2021 | 4.61% |